Annual accounts receivable:
$32.39M+$6.21M(+23.72%)Summary
- As of today (June 26, 2025), OCUL annual accounts receivable is $32.39 million, with the most recent change of +$6.21 million (+23.72%) on December 31, 2024.
- During the last 3 years, OCUL annual accounts receivable has risen by +$11.25 million (+53.24%).
- OCUL annual accounts receivable is now at all-time high.
Performance
OCUL Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$25.22M-$7.17M(-22.13%)Summary
- As of today (June 26, 2025), OCUL quarterly accounts receivable is $25.22 million, with the most recent change of -$7.17 million (-22.13%) on March 31, 2025.
- Over the past year, OCUL quarterly accounts receivable has dropped by -$1.32 million (-4.99%).
- OCUL quarterly accounts receivable is now -22.13% below its all-time high of $32.39 million, reached on December 31, 2024.
Performance
OCUL Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
OCUL Accounts receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +23.7% | -5.0% |
3 y3 years | +53.2% | +8.7% |
5 y5 years | +1171.1% | +635.5% |
OCUL Accounts receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +53.2% | -22.1% | +27.4% |
5 y | 5-year | at high | +1171.1% | -22.1% | +777.6% |
alltime | all time | at high | >+9999.0% | -22.1% | >+9999.0% |
OCUL Accounts receivable History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $25.22M(-22.1%) |
Dec 2024 | $32.39M(+23.7%) | $32.39M(+7.1%) |
Sep 2024 | - | $30.23M(+0.0%) |
Jun 2024 | - | $30.23M(+13.9%) |
Mar 2024 | - | $26.55M(+1.4%) |
Dec 2023 | $26.18M(+22.8%) | $26.18M(+11.0%) |
Sep 2023 | - | $23.59M(-13.6%) |
Jun 2023 | - | $27.31M(+29.3%) |
Mar 2023 | - | $21.12M(-0.9%) |
Dec 2022 | $21.32M(+0.9%) | $21.32M(+7.7%) |
Sep 2022 | - | $19.80M(-3.3%) |
Jun 2022 | - | $20.48M(-11.7%) |
Mar 2022 | - | $23.21M(+9.8%) |
Dec 2021 | $21.14M(+72.5%) | $21.14M(+8.1%) |
Sep 2021 | - | $19.55M(+4.4%) |
Jun 2021 | - | $18.73M(+37.4%) |
Mar 2021 | - | $13.63M(+11.3%) |
Dec 2020 | $12.25M(+380.8%) | $12.25M(+57.5%) |
Sep 2020 | - | $7.78M(+170.7%) |
Jun 2020 | - | $2.87M(-16.2%) |
Mar 2020 | - | $3.43M(+34.6%) |
Dec 2019 | $2.55M | $2.55M(+128.7%) |
Sep 2019 | - | $1.11M(+81.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $615.00K(+122.8%) |
Mar 2019 | - | $276.00K(+37.3%) |
Dec 2018 | $201.00K(-11.1%) | $201.00K(-16.3%) |
Sep 2018 | - | $240.00K(-15.8%) |
Jun 2018 | - | $285.00K(+67.6%) |
Mar 2018 | - | $170.00K(-24.8%) |
Dec 2017 | $226.00K(-9.6%) | $226.00K(-18.7%) |
Sep 2017 | - | $278.00K(+31.8%) |
Jun 2017 | - | $211.00K(-13.5%) |
Mar 2017 | - | $244.00K(-2.4%) |
Dec 2016 | $250.00K(+29.5%) | $250.00K(+2.9%) |
Sep 2016 | - | $243.00K(+9.0%) |
Jun 2016 | - | $223.00K(-1.8%) |
Mar 2016 | - | $227.00K(+17.6%) |
Dec 2015 | $193.00K(-41.3%) | $193.00K(+2.1%) |
Sep 2015 | - | $189.00K(+15.2%) |
Jun 2015 | - | $164.00K(-53.4%) |
Mar 2015 | - | $352.00K(+7.0%) |
Dec 2014 | $329.00K(+22.3%) | $329.00K(+509.3%) |
Sep 2014 | - | $54.00K(-11.5%) |
Jun 2014 | - | $61.00K(-80.1%) |
Mar 2014 | - | $306.00K(+13.8%) |
Dec 2013 | $269.00K(+497.8%) | $269.00K |
Dec 2012 | $45.00K | - |
FAQ
- What is Ocular Therapeutix annual accounts receivable?
- What is the all time high annual accounts receivable for Ocular Therapeutix?
- What is Ocular Therapeutix annual accounts receivable year-on-year change?
- What is Ocular Therapeutix quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly accounts receivable year-on-year change?
What is Ocular Therapeutix annual accounts receivable?
The current annual accounts receivable of OCUL is $32.39M
What is the all time high annual accounts receivable for Ocular Therapeutix?
Ocular Therapeutix all-time high annual accounts receivable is $32.39M
What is Ocular Therapeutix annual accounts receivable year-on-year change?
Over the past year, OCUL annual accounts receivable has changed by +$6.21M (+23.72%)
What is Ocular Therapeutix quarterly accounts receivable?
The current quarterly accounts receivable of OCUL is $25.22M
What is the all time high quarterly accounts receivable for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly accounts receivable is $32.39M
What is Ocular Therapeutix quarterly accounts receivable year-on-year change?
Over the past year, OCUL quarterly accounts receivable has changed by -$1.32M (-4.99%)